Patient education in the contemporary management of coronary heart disease
Related Experiment Video
Updated: Apr 23, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
7.7K
James Pr Brown1, Alexander M Clark2, Hayes Dalal3
1Anaesthetics Department, Musgrove Park Hospital, Taunton, UK.
The Cochrane Database of Systematic Reviews
|October 1, 2014
Insights
Patient education may improve outcomes for patients with coronary heart disease (CHD). This review assesses education
Area of Science:
- Cardiology
- Medical Education
- Evidence-Based Practice
Background:
- Coronary heart disease (CHD) poses significant mortality and morbidity risks.
- Effective management strategies for CHD are crucial for patient well-being.
- Patient education is a potential intervention to improve CHD outcomes.
Purpose of the Study:
- To evaluate the impact of patient education versus usual care on mortality and morbidity in CHD patients.
- To identify factors that may predict the effectiveness of patient education interventions in CHD.
Main Methods:
- Systematic review protocol for synthesizing evidence on patient education in CHD.
- Planned comparison of patient education with usual care.
- Exploration of study-level variables influencing intervention effects.
Main Results:
- This section is not applicable as this is a protocol for a review.
- Results will be reported upon completion of the systematic review.
Conclusions:
- The findings will inform clinical practice regarding patient education for CHD.
- Identifying predictors of effectiveness can help tailor educational interventions for better patient outcomes.
Abstract:
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of patient education compared with usual care on mortality and morbidity in patients with CHD.To explore the potential study level predictors of the effects of patient education in patients with CHD.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
887
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
887
01:26Angina IV: Management
483
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
483
01:27Coronary Artery Disease V: Interprofessional Care
442
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
01:26Atherosclerosis III: Management
634
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
634
01:20Angina V: Nursing Management
553
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
553
01:28Acute Coronary Syndrome IV: Interprofessional Care
514
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514